Cargando…

Diagnostic Performance of Electronic Nose Technology in Sarcoidosis

BACKGROUND: Diagnosing sarcoidosis can be challenging, and a noninvasive diagnostic method is lacking. The electronic nose (eNose) technology profiles volatile organic compounds in exhaled breath and has potential as a point-of-care diagnostic tool. RESEARCH QUESTION: Can eNose technology be used to...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Sar, Iris G., Moor, Catharina C., Oppenheimer, Judith C., Luijendijk, Megan L., van Daele, Paul L.A., Maitland-van der Zee, Anke H., Brinkman, Paul, Wijsenbeek, Marlies S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians 2022
Materias:	Diffuse Lung Disease: Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941620/ https://www.ncbi.nlm.nih.gov/pubmed/34756945 http://dx.doi.org/10.1016/j.chest.2021.10.025

Ejemplares similares

Managing Fatigue in Patients With Interstitial Lung Disease
por: Kahlmann, Vivienne, et al.
Publicado: (2020)

Exhaled breath analysis in interstitial lung disease
por: van der Sar, Iris G., et al.
Publicado: (2023)

OUTCOMES IN PATIENTS WITH SARCOIDOSIS DIAGNOSED WITH COVID-19
por: NADEEM, OWAIS, et al.
Publicado: (2021)

MULTISYSTEM SARCOIDOSIS ASSOCIATED WITH THE COVID-19 MRNA VACCINE
por: MITMA, ANGEL A, et al.
Publicado: (2022)

First patient-centred set of outcomes for pulmonary sarcoidosis: a multicentre initiative
por: Kampstra, Nynke A, et al.
Publicado: (2019)

Needs, Perceptions and Education in Sarcoidosis: A Live Interactive Survey of Patients and Partners
por: Moor, C. C., et al.
Publicado: (2018)

Sarcoidosis: An Occupational Disease?
por: Oliver, L. Christine, et al.
Publicado: (2021)

Efzofitimod for the Treatment of Pulmonary Sarcoidosis
por: Culver, Daniel A., et al.
Publicado: (2023)

High-Definition Videobronchoscopy for the Diagnosis of Airway Involvement in Sarcoidosis: The Enhance Sarcoidosis Multicenter Study
por: Livi, Vanina, et al.
Publicado: (2023)

ELECTRONIC VAPE-ASSOCIATED LUNG INJURY: A UNIQUE PRESENTATION
por: Hawk, Fahad, et al.
Publicado: (2020)

FIBROTIC PROTEASE 3 ANCA-ASSOCIATED VASCULITIS
por: Megri, Mohammed, et al.
Publicado: (2020)

CHILDHOOD-ONSET INTERSTITIAL LUNG DISEASE: A RARE CASE OF IDIOPATHIC, NONSPECIFIC INTERSTITIAL PNEUMONIA IN A TEENAGER
por: Cerro, Giuliana, et al.
Publicado: (2020)

AN UNUSUAL PRESENTATION OF NONSPECIFIC INTERSTITIAL PNEUMONIA
por: Matta, Atul, et al.
Publicado: (2020)

NOT ALL ARDS IS COVID: THE RISK OF PREMATURE CLOSURE AND THE VALUE OF MULTIDISCIPLINARY DISCUSSION
por: VARGAS, JORGE, et al.
Publicado: (2021)

THE PERFECT STORM: DIFFUSE ALVEOLAR HEMORRHAGE AFTER SARS-COV-2 INFECTION
por: WANG, EDWARD, et al.
Publicado: (2021)

THINKING BEYOND COVID-19: A CASE OF KRATOM-INDUCED PNEUMONITIS
por: MINICH, CORBYN, et al.
Publicado: (2021)

PULMONARY ALVEOLAR PROTEINOSIS SUBMITTED A WHOLE LUNG LAVAGE AFTER COVID-19: A CASE REPORT
por: D'AMBROSIO, PAULA, et al.
Publicado: (2021)

COVID-19 VACCINE UPTAKE IN AN INTERSTITIAL LUNG DISEASE CLINIC
por: LEAHY, AMY, et al.
Publicado: (2021)

A CASE OF STEROID RESPONSIVE SEVERE PNEUMONIA RELATED TO IMMUNE-LIKE RECONSTITUTION INFLAMMATORY RESPONSE 3 MONTHS AFTER RITUXIMAB THERAPY FOR PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH STREPTOCOCCAL INFECTIONS
por: POURSHAHID, SEYEDMOHAMMAD, et al.
Publicado: (2021)

A CASE OF SEVERE HYPOXEMIA AND HEMOPTYSIS SECONDARY TO E-CIGARETTE AND VAPING PRODUCT USE-ASSOCIATED LUNG INJURY IN COVID-19 ERA
por: POLISETTY, LAKSHMI, et al.
Publicado: (2021)

ORGANIZING PNEUMONIA FOLLOWING COVID-19: A REPORT OF 8 CASES
por: BETHLEM, MARCOS, et al.
Publicado: (2021)

A CASE OF SEVERE E-CIGARETTE OR VAPING PRODUCT USE-ASSOCIATED LUNG INJURY IN THE TIME OF COVID-19
por: WASSERMAN, EVAN, et al.
Publicado: (2021)

MORTALITY AND ITS PREDICTORS IN PATIENTS WITH COVID-19 WITH PREEXISTING INTERSTITIAL LUNG DISEASE
por: DUTT, N., et al.
Publicado: (2022)

AGGRESSIVE AND RAPID NASCENT HONEY COMBING DURING ACUTE COVID-19 INFECTION: A CASE REPORT
por: JOSHI, V., et al.
Publicado: (2022)

A CASE REPORT OF COMPLICATIONS IN A SURVIVOR OF SEVERE COVID-19: PULMONARY FIBROSIS AND LONG-TERM SUPPLEMENTAL OXYGEN REQUIREMENT
por: YANAMADALA, A.
Publicado: (2022)

EXTENSION OF STEROID THERAPY FOR POST-COVID-19 FIBROTIC LUNG SEQUALAE
por: TOUMAN, A., et al.
Publicado: (2022)

ORGANIZING PNEUMONIA AS A SIDE EFFECT OF COVID-19 VACCINE
por: DADHWAL, R., et al.
Publicado: (2022)

PREDICTORS OF POST-COVID-19 PULMONARY FIBROSIS: A CASE SERIES
por: CÎRJALIU, R.-E., et al.
Publicado: (2022)

DERMATOMYOSITIS AFTER COVID-19 PNEUMONIA
por: KHANAM, VERISHA, et al.
Publicado: (2022)

WITHDRAWN
Publicado: (2022)

PUTTING THE "SARS” IN "SARS-COVID-19": A CASE OF SARCOID-LIKE INFLAMMATORY REACTION AFTER COVID-19 VACCINATION
por: JAFRI, MUSTAFA HUS, et al.
Publicado: (2022)

COVID-19 PNEUMONIA AND PERICARDITIS IN A PATIENT WITH UNTREATED CYSTIC LUNG DISEASE
por: KOZLIK, ANN, et al.
Publicado: (2022)

COVID-19 VACCINE-RELATED PNEUMONITIS
por: TSENG, CHENGTIN, et al.
Publicado: (2022)

Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary Sarcoidosis
por: Drake, Wonder P., et al.
Publicado: (2021)

Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology
por: van der Sar, Iris G., et al.
Publicado: (2023)

Feasibility of a Comprehensive Home Monitoring Program for Sarcoidosis
por: Moor, Catharina C., et al.
Publicado: (2019)

Comprehensive Care for Patients with Sarcoidosis
por: Moor, Catharina C., et al.
Publicado: (2020)

Patient reported side-effects of prednisone and methotrexate in a real-world sarcoidosis population
por: Kahlmann, Vivienne, et al.
Publicado: (2021)

Physical Inactivity in Pulmonary Sarcoidosis
por: Cho, Peter S. P., et al.
Publicado: (2019)

Repository corticotropin for Chronic Pulmonary Sarcoidosis
por: Baughman, Robert P., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bvln89ndamvjvo75129m98m81e